Skip to main content
. 2018 Feb 1;2018(2):CD004879. doi: 10.1002/14651858.CD004879.pub5

Comparison 5. All vaccine types versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Influenza 9 8227 Risk Ratio (M‐H, Random, 95% CI) 0.30 [0.19, 0.45]
1.1 Live attenuated vaccines (1 dose) 5 3556 Risk Ratio (M‐H, Random, 95% CI) 0.33 [0.18, 0.62]
1.2 Live attenuated vaccines (2 doses) 2 3043 Risk Ratio (M‐H, Random, 95% CI) 0.11 [0.04, 0.26]
1.3 Inactivated vaccines (1 dose) 5 1628 Risk Ratio (M‐H, Random, 95% CI) 0.36 [0.28, 0.48]
1.4 Inactivated vaccines (2 doses) 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Influenza‐like illness 8 143650 Risk Ratio (M‐H, Random, 95% CI) 0.69 [0.62, 0.77]
2.1 Live attenuated vaccines (1 dose) 2 3306 Risk Ratio (M‐H, Random, 95% CI) 0.64 [0.18, 2.22]
2.2 Live attenuated vaccines (2 doses) 6 121300 Risk Ratio (M‐H, Random, 95% CI) 0.66 [0.57, 0.76]
2.3 Inactivated vaccines (1 dose) 2 267 Risk Ratio (M‐H, Random, 95% CI) 0.35 [0.15, 0.81]
2.4 Inactivated vaccines (2 doses) 2 18777 Risk Ratio (M‐H, Random, 95% CI) 0.72 [0.69, 0.76]
3 Secondary cases 1 123 Risk Ratio (M‐H, Random, 95% CI) 1.68 [0.56, 4.99]
3.1 Live attenuated vaccines (1 dose) 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
3.2 Live attenuated vaccines (2 doses) 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
3.3 Inactivated vaccines (1 dose) 1 123 Risk Ratio (M‐H, Random, 95% CI) 1.68 [0.56, 4.99]
3.4 Inactivated vaccines (2 doses) 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
4 School absenteeism 1 550 Risk Ratio (M‐H, Random, 95% CI) 0.49 [0.26, 0.92]
4.1 Live attenuated vaccines (1 dose) 1 296 Risk Ratio (M‐H, Random, 95% CI) 0.51 [0.22, 1.19]
4.2 Live attenuated vaccines (2 doses) 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
4.3 Inactivated vaccines (1 dose) 1 254 Risk Ratio (M‐H, Random, 95% CI) 0.46 [0.17, 1.22]
4.4 Inactivated vaccines (2 doses) 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
5 Lower respiratory tract disease 2 1632 Risk Ratio (M‐H, Random, 95% CI) 0.20 [0.03, 1.54]
5.1 Live attenuated vaccines (1 dose) 2 1496 Risk Ratio (M‐H, Random, 95% CI) 0.16 [0.01, 4.45]
5.2 Live attenuated vaccines (2 doses) 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
5.3 Inactivated vaccines (1 dose) 1 136 Risk Ratio (M‐H, Random, 95% CI) 0.30 [0.01, 6.17]
5.4 Inactivated vaccines (2 doses) 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
6 Acute otitis media 6 5253 Risk Ratio (M‐H, Random, 95% CI) 1.00 [0.79, 1.26]
6.1 Live attenuated vaccines (1 dose) 3 2585 Risk Ratio (M‐H, Random, 95% CI) 0.42 [0.05, 3.79]
6.2 Live attenuated vaccines (2 doses) 1 1784 Risk Ratio (M‐H, Random, 95% CI) 0.98 [0.95, 1.01]
6.3 Inactivated vaccines (1 dose) 1 136 Risk Ratio (M‐H, Random, 95% CI) 1.52 [0.10, 23.76]
6.4 Inactivated vaccines (2 doses) 2 748 Risk Ratio (M‐H, Random, 95% CI) 1.15 [0.95, 1.40]
7 Hospitalisation due to acute otitis media 2   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
7.1 Inactivated vaccine (2 doses) 2 765 Risk Ratio (M‐H, Random, 95% CI) 1.41 [0.62, 3.24]
8 Consequences of acute otitis media 2   Mean Difference (IV, Random, 95% CI) Subtotals only
8.1 Inactivated vaccine (2 (doses of the intervention) ‐ visits (outcome measure)) 2 765 Mean Difference (IV, Random, 95% CI) ‐0.02 [‐0.27, 0.23]
8.2 Inactivated vaccine (2 doses; courses of antibiotics) 2 765 Mean Difference (IV, Random, 95% CI) 0.13 [‐0.36, 0.63]
9 Outpatients attendance for pneumonia and influenza 2 2874 Risk Ratio (M‐H, Random, 95% CI) 0.76 [0.59, 0.98]
9.1 Live attenuated vaccine (1 dose) 1 1090 Risk Ratio (M‐H, Random, 95% CI) 0.65 [0.49, 0.85]
9.2 Live attenuated vaccine (2 doses) 1 1784 Risk Ratio (M‐H, Random, 95% CI) 0.85 [0.75, 0.96]
10 Working days lost (number of events, parents of children 6 to 36 months of age) 2 2874 Risk Ratio (M‐H, Random, 95% CI) 0.69 [0.46, 1.03]
10.1 Live attenuated vaccine 2 2874 Risk Ratio (M‐H, Random, 95% CI) 0.69 [0.46, 1.03]
11 Drug prescriptions (number of events, 6 to 36 months of age) 1 1784 Risk Ratio (M‐H, Random, 95% CI) 0.99 [0.87, 1.12]
11.1 Live attenuated vaccine 1 1784 Risk Ratio (M‐H, Random, 95% CI) 0.99 [0.87, 1.12]